Lilly facility coming to West Creek (Eli Lilly image) |
Virginia Governor Glen Youngkin, Lieutenant Governor Winsome
Earle Sears, and Virginia Secretary of Commerce and Trade Juan Pablo Segura
welcomed the Eli Lilly company to the Commonwealth, and more importantly, to Goochland
at an event held at Main Street Station in Richmond on September 16.
Those who worked to bring Lilly to Goochland |
Goochland was well represented at the event by State Senator Luther Cifers, Delegates Tom Garrett and David Owen; Supervisors Jonathan Christy, Neil Spoonhower, Tom Winfree, Charlie Vaughters and Jonathan Lyle; County Administrator Dr. Jeremy Raley, Deputy County Administrators Josh Gillespie and Sara Worley, Deputy Director of Economic Development Chance Robinson; Superintendent of Schools Dr. Andy Armstrong; EDA members Ben Slone, Ken Collier, Jennie Slade, D. B. Smit, Lisa Dearden, and Carol Taylor executive director of the Goochland Chamber of Commerce.
After a brief video about
how Lilly brings life-changing medicines to those who need them, Lilly CEO David
A. Ricks announced that the company will invest $ 5 billion—yes with a B—in Goochland
to build a more than 200k square foot advanced pharmaceutical manufacturing facility.
In addition to creating an estimated 650 highly skilled jobs including engineers,
scientists, operations personnel, and lab technicians to operate the facility,
it will generate 1,800 construction jobs. He anticipated that most of those
jobs would be filled by Virginians. This is part of a $50 billion capital expenditure
expansion that will include three other facilities around the country.
Lilly, Ricks explained, is an American company founded 149
years ago guided by a simple principle “investing in American innovation, communities,
and workers, making America healthier.”
Virginia and Goochland were selected in a highly competitive
process that included more than 400 sites in 46 states across the country. Criteria
that won Lilly over included workforce potential in the Richmond region, local
incentives, zoning, and access to utilities and transportation, said Ricks. Virginia
also has talent in place to operate and build the site in what he hopes will be
record time, and a partnership-oriented attitude that moves projects into
production also got high marks.
Goochland’s application, said Ricks, was one of the
strongest on paper. Two factors set Goochland apart: the speed to build and develop
the site, which he said was beyond shovel ready and even has parking lots, which
lets us get a running start. The patient needs the medicine; we don’t have time
to waste. Second, the people, all the necessary partners, were involved from
the start with a team approach that was committed to our success.
The site selected in West Creek is currently owned by Markel
Properties LLC and used as a soccer facility. The 227-acre parcel is assessed
by Goochland County at $23, 967,700 and has not yet changed hands. It is roughly
opposite Hardywood Creek Brewery in an area set aside for industrial and
business use for at least 35 years.
This Lilly facility, the first of several new sites planned for
the United States, will make cancer, autoimmune, and other advanced therapies.
It will be the company’s first dedicated, fully integrated active pharmaceutical
ingredients (API)and drug product plant for its emerging biconjugate platform
and multiclonal antibody portfolio. At over 200k square feet, it will be the
largest facility of its kind in the world.
“We united science and manufacturing to speed medicine to
patients,” Ricks said. The facility will make some of the most complex
therapies known in medicine and advanced technology to ensure precision in every
step, medicine at the cutting edge of science.
The company is committed to its 2030 climate goals of having
carbon neutral operation powered by 100 percent renewal energy, zero waste to
landfills, and reduction of all other emission types.
Lily is also committed to partner with local education systems
and workforce programs to create pathways into advanced manufacturing careers
with high paying life-changing jobs. Every dollar that Lilly invests in a
community generates up to four dollars of local economic activity.
Ricks thanked all who made the investment possible, and the warm
Virginia welcome.
“Lilly defines the standards for building new advanced manufacturing
in our country that scale innovation and create an export economy. The company is
committed to making life saving therapies in America. By expanding our domestic
capacity, we're building a secure, resilient supply chain that delivers for
patients today and supports the breakthrough medicines of tomorrow.”
Ricks said that it could take five years to build the facility,
including regulatory approval, but he hopes it will be done sooner. Site work
and permitting in the next few weeks.
Youngkin said the plant location was one of the premier
shovel ready sites in Virginia. He thanked Goochland for its investment in the process.
The Governor said that the Virginia talent accelerator, run by the Virginia
Economic Development Partnership, for the third consecutive year, has been recognized
for having the most customized workforce development program in America.
“We look forward to work with Lilly to build that workforce.
Virginia went to work a long time ago partnering with our community colleges to
build programs offering advanced manufacturing credentials.” He also pointed
out that Virginia Commonwealth University’s programs in biomedical engineering,
and related subjects created a life science ecosystem that puts our state ahead
of those around us in having a highly qualified “talent pipeline” ready to
staff the new facility. The Governor contended that this created a sustainable environment
that must be maintained to “keep Virginia soaring”.
Ricks said that Lilly employees often come from other jobs
and that his company uses a “grow from within” approach. Companies, said Ricks,
vote with their feet. He recommends Virginia highly for anyone looking for
advanced manufacturing sites.
Goochland supervisors worked closely with the EDA and economic
development department, including trips to Lilly’s headquarters in Indianapolis
to close the deal. Funds appropriated by the Board to allow the EDA to promote what
became the Lilly site got a fast return on investment.
The announcement is good news for Goochland, and the result
of the Board of Supervisors’ commitment to diversifying the tax base to fund
needed infrastructure and lighten the tax burden on property owners. The Lilly
facility is in the right place at the right time. Kudos to all involved.